Related Experiment Video
Updated: Mar 28, 2026
08:45
LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring
Published on: November 17, 2018
14.2K
[Statin intolerance and associated muscular dysfunctions].
Antoine Boulanger-Piette1, Jean Bergeron1, Joël Desgreniers2
1Centre de recherche du CHU de Québec-CHUL, université Laval, 2705, boulevard Laurier, Québec, QC, G1V 4G2 Canada.
Medecine Sciences : M/S
|December 18, 2015
Summary
Statins effectively treat high cholesterol but can cause muscle problems. This review clarifies statin-induced myopathy mechanisms to improve patient care and cardiovascular risk management.
Area of Science:
- Cardiology
- Pharmacology
- Muscle Physiology
Background:
- Hypercholesterolemia is a significant cardiovascular disease risk factor.
- Dyslipidemia affects 38% of Canadian adults (18-79 years).
- Statins are the primary treatment for dyslipidemia and cardiovascular risk reduction.
Purpose of the Study:
- To review the clinical landscape of statin use.
- To investigate the mechanisms underlying statin-induced myopathy.
- To enhance understanding of muscle pathology in statin users.
Main Methods:
- Literature review of clinical data and research on statins.
- Analysis of molecular mechanisms related to statin myotoxicity.
- Examination of interactions between statins and exercise.
Main Results:
- Statins are crucial for managing dyslipidemia and cardiovascular risk.
- Concerns exist regarding statin safety, particularly muscular side-effects.
- Understanding myotoxicity mechanisms is vital for clinical management.
Conclusions:
- A comprehensive understanding of statin-induced myopathy is essential.
- Minimizing muscle symptoms in statin users requires further research.
- This knowledge will support evidence-based cardiovascular risk management.
Related Concept Videos
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
1.8K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.8K
01:21Skeletal Muscle Relaxants: Adverse Effects
1.1K
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Unlike...
1.1K
01:28Disorders of the Skeletal Muscle
2.3K
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
2.3K
01:26Atherosclerosis III: Management
582
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
582
01:20Myasthenia Gravis: Overview and Treatment
3.4K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
3.4K
01:28Classification of Skeletal Muscle Relaxants
3.3K
Skeletal muscle relaxants are a group of drugs that can reduce muscle stiffness and induce temporary paralysis to relieve pain. These agents can act centrally to reduce muscle tone or spasms in painful conditions such as multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), or spinal injuries; they are called antispasmodics or spasmolytics.
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
3.3K